Protein based COVID-19 vaccine

Description

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Jane Elliott AM & Prof Rod Baber AM

Dr Jane Elliott AM & Prof Rod Baber AM

Non-Hormonal Options for Menopausal Symptoms

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Holter Monitoring in GP – Cases and Practical Tips

Dr Rupert Hinds

Dr Rupert Hinds

Management of Constipation in Children

A/Prof Greg Katsoulotos

A/Prof Greg Katsoulotos

Inhaler Devices – Common User Errors

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 12 July 2023